Description: Sinil Pharmaceutical Co., Ltd. manufactures, markets, and sells pharmaceutical products in South Korea. It provides over the counter products, including products for headache, myalgia, pain, dyspepsia, heartburn, diarrhea, common cold, cough, sputum, allergy, anorexia, physical fatigue, liver disease, xerophthalmia, asthenopia, pregnant woman, athletes foot, skin wound, cutaneous disorder, herpes, virus infection, osteoarthritis, neuralgia, peripheral neuritis, peripheral nerve p, iron deficiency anemia, bronchitis, gastritis, colitis, hemorrhoid, venous insufficiency, ecchymosis, reti, hypertension, rhinitis, constipation, eczematous dermatitis, calcium deficiency, withdrawal, and alopecia, as well as interruption in blood circulation and climacteric. The company also offers products for respiratory diseases and liver, as well as circulator therapies; therapies for digestive system, diabetes mellitus, osteoporosis, and dysuria, as well as other therapies; and central nervous system depressants, anti-biotics, anti-viral agents, anti-protozoal agents, analgesics, febricides, muscle relaxants, anti-inflammatory agents, anti-histamines, adrenocortical hormones, vitamin preparations, and injection. In addition, the company provides drugs for animals; household medicines; cosmetics under the PHARMTREE brand name; and health functional foods and other products, as well as contract manufacturing organization and original development manufacturing services. It offers products in the form of tablets, hard capsules, plasters/patches and ointments, sold soft capsules, syrups, liquid injection, and powder injections. The company also exports its products. Sinil Pharmaceutical Co., Ltd. was founded in 1971 and is based in Seoul, South Korea.
Home Page: www.sinilpharm.com
272, Sagajeong-ro
Seoul,
South Korea
Phone:
82 2 2211 6700
Officers
| Name | Title |
|---|---|
| Mr. Mi-Keun Jung | Chief Exec. Officer and Pres |
| Jae-Hyun Hong | Sr. Managing Director |
| Jong-Chang Park | Managing Director |
| Young-Shin Ok | Managing Director |
| Jung-Min Lee | Managing Director and Head of Research Center |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.9952 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |